Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-12-16 16:04 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
33,053 | |
Filed 2021-12-13 17:07 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
12,871 | |
Filed 2021-12-13 17:06 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-11-13 12:27 Tx date 2020-11-09 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$155,600
+10,000 vol $15.56 each |
86,674 | |
Filed 2019-06-11 10:39 Tx date 2019-06-07 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,857
+11,695 vol $15.55 each |
76,674 | |
Filed 2018-08-23 Tx date 2018-08-22 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$71,382
+8,559 vol $8.34 each |
64,979 | |
Filed 2018-03-14 Tx date 2018-03-12 |
$HLS
HLS Therapeutics Inc. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
56,420 | ||
Filed 2015-11-18 Tx date 2015-11-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,020
+38,000 vol $0.79 each |
155,474 | |
Filed 2015-11-16 Tx date 2015-11-12 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$82,000
+100,000 vol $0.82 each |
225,000 | |
Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$31,500
+75,000 vol $0.42 each |
||
Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$31,125
+75,000 vol $0.415 each |
125,000 | |
Filed 2015-08-20 Tx date 2013-11-05 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-08-20 Tx date 2015-08-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$39,999
+117,474 vol $0.3405 each |
117,474 | |
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$7,700
+5,000 vol $1.54 each |
5,000 | |
Filed 2015-05-01 Tx date 2013-12-18 |
$HBP
Helix BioPharma Corp. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-01 Tx date 2013-12-18 |
$HBP
Helix BioPharma Corp. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-05-01 Tx date 2015-04-29 |
$HBP
Helix BioPharma Corp. |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,500
+5,000 vol $1.10 each |
5,000 |